Table 2.

Individual Demographics and Clinical Characteristics of 20 Patients (9 Women and 11 Men) With NAFLD Analyzed in This Study

Patient	Diagnosis	Sex	Age, y	Weight, kg	ALT level, IU/mL	Fibrosis grade (Clinical Research Network)	H&E (total NAS score)	IF IL22+ cells
Men (N = 11)
LB051	NAFLD	M	62	62	53	F2	6	√
LB054	NASH	M	41	124	249	F3	5	√
LB059	NASH	M	52	80	66	F0	1	√
LB078	NASH	M	57	93.2	195	F2	2	√
LB084	NAFLD	M	33	76	138	F1–F2	5	√
LB099	NAFLD	M	66	N/A	12	F1	2	√
LB102	NASH	M	38	101	65	F0	3	√
LB123	NAFLD	M	52	102	35	F3	5	√
LB125	NAFLD	M	43	140	196	F3	6	√
LB130	NAFLD	M	35	81	115	F2	6	√
LB133	NAFLD	M	61	109.4	16	F1	1	√
Women (N = 9)
LB062	NASH	F	59	100.4	58	F4	5	√
LB076	NASH	F	25	100	138	F1	6	√
LB079	NAFLD	F	52	55	23	F4	2	√
LB093	NASH	F	37	N/A	19	F2	6	√
LB097	NASH	F	62	89	204	F3–F4	3	√
LB118	NASH	F	40	120	45	F2	5	√
LB119	NASH	F	73	93	51	F4	6	√
LB128	NASH	F	51	63	94	F2	7	√
LB131	NASH	F	52	90.7	46	F3–F4	4	√